April 20, 2021
3 min read
Majzner RG, et al. Abstract CT031. Presented at: American Association for Cancer Research Annual Meeting (virtual meeting); April 10-15, 2021.
Parker Institute for Cancer Immunotherapy and CureSearch sponsored the study. Majzner reports consultant roles with Aptorum Group, GammaDelta Therapeutics, Illumina Radiopharmaceuticals, Lyell Immunopharma, SU xDA Pharmaceuticals and Zai Laboratories, and is co-founder and equity holder in Syncopation Life Sciences. He also holds multiple patents for CAR T-cell therapy, including…